Innovative Non-Invasive Therapy For Heart Recovery

Enhance your patients outcomes in your practice with Flow Therapy Enhanced External Counter Pulsation [EECP]

Patient Candidates For EECP

Obstructive Coronary Artery Disease

Not readily amenable for intervention: symptomatic, obstructive CAD without a clear target to revascularize

Symptomatic Microvascular Disease

Exertional symptoms without obstructive lesions; Believed to be due to reduced flow in the microcirculation

Ischemic Heart Failure

Heart failure with underlying ischemia, regardless of ejection fraction. Continued symptoms despite medical therapy and at increased risk of hospitalization

We Make Patient Referrals Easy

Add to your cardiology care options with safe, durable, counterpulsation therapy.

Backed By Research

There are more than 430 peer-reviewed publications demonstrating the safety and efficacy of counterpulsation therapy. Read about the strong data supporting this innovative treatment modality.

Flow Therapy By The Numbers

40,000+

Every year, Flow Therapy performs 40,000+ EECP treatments.

Trusted

Trusted by providers at leading institutions like Mayo Clinic, Cleveland Clinic, and Johns Hopkins.

1,000+

Every year, more than 1000 clinicians refer their patients to Flow Therapy.

Lasting

Research shows that the benefits of EECP persist for 2-5 years post-treatment.

90%

90% of patients complete the full 35-session treatment course at Flow Therapy.

88%

88% of patients experience significant improvement of symptoms.

Covered

EECP Flow Therapy is FDA approved, and covered by Medicare and all commercial insurances.

91%

Flow Therapy’s approach to EECP delivery has earned a customer satisfaction score of 91 out of 100.

Discover More About EECP For Improved Patient Outcomes And Satisfaction